Outlook Therapeutics (OTLK) Misses Q3 EPS by 44c

August 14, 2025 4:15 PM EDT

Outlook Therapeutics (NASDAQ: OTLK) reported Q3 EPS of ($0.44). Revenue for the quarter came in at $1.51 million.

For earnings history and earnings-related data on Outlook Therapeutics (OTLK) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK